ArticleCancers2021

Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases.

Jean-Matthieu L'Orphelin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.